RELIABLE AND FAST RESULTS
Test results are available in just 5 minutes at the bedside and are not affected by intercourse, semen, urine, vaginal medications, lubricants, bathing products or infections.
Clinical evidence from multiple studies shows that Actim® Partus has a very high (98%) negative predictive value (NPV) as a predictor of delivery before week 32–37 and within 7 days1-9.
EARLY PREDICTION OF PRETERM OR IMMINENT DELIVERY
The Actim® Partus 1ngeni test is conducted using cervical secretions collected from women with intact fetal membranes and can be performed from gestational week 22 onwards. Accurate detection of an elevated risk is crucial for choosing the right treatment early.
CLEAR QUANTIFICATION AND INTERPRETATION OF TEST RESULTS
The phIGFBP-1 concentration is reported as a numerical value with the description of the estimated risk for preterm or imminent labour:
- < 10 μg/l, low risk of preterm delivery
- ≥ 10 μg/l, elevated risk of preterm delivery
FAST AND EASY TESTING WITH TRACEABLE DOCUMENTATION
Automated testing and digital data storage save time and ensure assay consistency.